ORTEXORTEX News
Tracking EQH? Get live short interest, options flow, and signals on ORTEX.Sign up free →
EQ
Earnings PreviewEQH

EQH Earnings Day: Corebridge Deal Still the Main Event

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 3 Nov 2026, 04:14

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Equitable Holdings reports Q3 results today with the quarterly print almost beside the point: the agreed acquisition of Corebridge Financial continues to dominate the investment case, setting off index rebalance expectations that dwarf anything the earnings figures are likely to deliver on their own.

The index mechanics are the most concrete near-term catalyst. ORTEX puts an 84% probability on the Corebridge deal triggering a share-count increase in the Russell 1000 and Russell 3000, with 80% odds for the S&P MidCap 400 and S&P TMI, and 65% for the MSCI World Small. The MSCI scenario alone carries an estimated $657 million of required index-tracker buying. All dates remain estimated, announcements are expected around late December, effective December 31, and no index provider has confirmed anything yet. These are forecasts, not announcements.

Positioning reflects the calm backdrop rather than any particular anxiety about the numbers. The put/call ratio at 0.23 is fractionally above its 20-day average of 0.22, a third of a standard deviation from the norm and nowhere near the 52-week high of 2.71. Short interest has been declining steadily, falling roughly 14% over the past month to just under 2% of the free float. The borrow market is entirely relaxed: 271 million shares remain available relative to fewer than 6 million currently shorted, and borrowing costs, while up 15% on the week, remain at 0.61%, well within noise for a stock of this size. EQH edged up 1.3% over the past week, modestly behind the peer median of around 2.2%.

Analyst sentiment has been uniformly constructive in the run-up, with covering firms raising targets rather than cutting them through October. Wells Fargo lifted its target to $65 and Barclays moved to $61, both maintaining positive ratings. The Street mean target of $64 implies roughly 18% upside from the current price of $54.26. One notable institutional move: T. Rowe Price lifted its disclosed stake to 6.7% of the class, up from 5.5%, according to a Schedule 13G/A filed in August. Canada Pension Plan Investment Board moved the other way, trimming from 6.7% to 3.3% over the same period. Stakes are as last disclosed around the 5% threshold; holders dropping below that level may not file again.

Today's print will test whether the underlying business, annuities, asset management, and life insurance, is keeping pace with a valuation that has re-rated steadily higher, or whether the deal premium has run ahead of the fundamentals.

Stocks in this article

See the live data behind this article on ORTEX.

Open EQH on ORTEX →

How this article was generated

Generated
3 Nov 2026, 05:20
Data as of
3 Nov 2026, 04:14
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex RebalancePrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.